Presage Biosciences
Presage Biosciences develops and offers the CIVO platform, a patented technology that delivers microdoses of multiple drugs directly into different regions of a tumor within a patient to observe molecular and cellular responses. This platform provides detailed insights into the tumor microenvironment, supporting oncology researchers and drug developers in evaluating drug candidates and combinations more effectively. Its mission is to improve cancer drug development and targeting, aiming to provide more effective treatments for patients with cancer.
Facts
- HQ
- Seattle
- Sectors
- Biotechnology, Oncology, Life Sciences
- Founded
- 2010 Seattle business license
- Type
- Corporation Seattle business license
- Registered name
- Presage Biosciences Inc Seattle business license
- Stage
- Seed
Is this your organization? Claim it
Recent coverage
Front-page news, podcasts and videos about Presage Biosciences
Presage Biosciences raises $13M, inks collaborations with Merck and Maverick to test cancer drugs using CIVO
Seattle-based Presage Biosciences raised $13 million in its first venture round, bringing total equity to $35 million, and announced new collaborations with Merck and Maverick Therapeutics to use its CIVO platform for testing cancer drugs in human tumors. The CIVO device enables micro-dosing and biomarker tracking in phase 0 trials, aiming to improve preclinical screening and reduce failures in costly phase I trials.
Presage Biosciences raises $6M from Takeda and Celgene, names Rich Klinghoffer CEO to scale CIVO tumor microdosing platform
Presage Biosciences raised $6 million led by Takeda and Celgene to expand use of its CIVO platform, which microdoses cancer drugs into human tumors to speed early testing, and appointed Rich Klinghoffer as CEO while founder Nathan Caffo becomes a strategic advisor.
Online
Questions about Presage Biosciences
What is Presage Biosciences?
presagebio.com
Who invested in Presage Biosciences, and how much has it raised?
Members of Seattle Flow see Presage Biosciences' funding rounds, amounts and investors on its Funding tab. Joining is free.
Where is Presage Biosciences based?
Presage Biosciences is headquartered in Seattle.
When was Presage Biosciences founded?
Presage Biosciences was founded in 2010.